Mark Kidd, Ph.D., DABCC has worked and published extensively in the area of Neuroendocrine Tumor (NET) disease and is the Scientific Director of Wren Laboratories. He is also the CAP- and CLIA-certified Laboratory Director and Technical Consultant for Wren Laboratories. His professional and academic research interests have focused on the biology of neuroendocrine cells and the development of tumor models of the disease. Dr. Kidd’s publications cover diverse areas including global gene analysis, tissue microarrays, tumor biology, bacterial genetics as well as gastric and pancreatic pathology. Dr. Kidd has more than twenty years of molecular and cancer biology laboratory experience focused on oncology and other disciplines.